knowledge -WSS

knowledge

author：knowledge 2025-10-02 11:10:12 - browse：817

Principal Deputy FDA Commissioner Janet Woodcock Stefani Reynolds/The New York Times via AP

WASHINGTON — Principal Deputy FDA Commissioner Janet Woodcock will retire early next year from the Food and Drug Administration after helping steer the agency through an historic period of medical advances during nearly four decades in key leadership positions, she confirmed to STAT Thursday.

Woodcock, a doctor with a chemistry degree, joined FDA in 1986 at its biologics center, where she oversaw the approval of the first biotechnology-based treatments for multiple sclerosis and cystic fibrosis. In 1994, she was named director of the drug center, where she played a key role in guiding some of the most impactful changes to the regulation of medicine, according to Trump administration FDA Commissioner Scott Gottlieb.

Woodcock envisioned that antibody drugs would become a backbone of therapy and created a more predictable regulatory path for their review and approval, Gottlieb said. She presided over a major expansion and modernization of the generic drug program, standardizing reviews in a way that allowed the industry to become safer and more robust, and crafted the reform of over-the-counter drug reviews.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： WHO recommends dropping component of many flu vaccines

WSS

Data show record exodus of life scientists from academia

Did you have Obamacare on your GOP debate bingo card?

Ozempic has benefits for kidney disease as well as diabetes

Why Talkspace is targeting Medicare, a tricky market

Ancient Greek ideas underpin modern concepts of pregnancy

Stem cell biologist probes earliest stages of human development

leisure time

knowledge

Wikipedia

Cancer drug shortages should be causing more outrage

Fetal cell organoids grown from amniotic fluid, study finds

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Paxlovid should be available without a positive Covid test

Wildfire smoke exposes gaps in outdoor worker protections

Cigna to pay $172 million to settle Medicare Advantage fraud probe

Guidelines to prevent youth baseball injuries need more muscle

Address the ethical violations that led to 'Three Identical Strangers'

State Dept. review finds Biden bears some blame for Afghanistan failures

Stem cell biologist probes earliest stages of human development

focus

How one patient went off dialysis — and others can too

Longer MASH drug regimen improved liver, Akero study finds

State of the Union pitch: Bigger Medicare drug price negotiations

Listen: Who gets the credit for GLP

Senator probes 340B programs at Cleveland Clinic, Bon Secours

Senator probes 340B programs at Cleveland Clinic, Bon Secours

knowledge

knowledge

explore

entertainment